Sage Journals: Discover world-class research

Open access

Research article

First published 2020

Prognostic factors for steroid-free remission in patients with idiopathic inflammatory myopathies: importance of anthropometric measurements

Jung Sun Lee, Jung Eun Lee, Seokchan Hong [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2024

Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn’s disease: a prospective,real-world observational study including patient-reported outcomes (POLONEZ II)

Ariel Liebert, Maria Kłopocka, Agata Michalak [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2022

Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study

Stephan R. Vavricka, Thomas Greuter, Benjamin L. Cohen [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2024

Effectiveness comparison between ustekinumab and infliximab for Crohn’s disease complicated with intestinal stenosis: a multicenter real-world study

Xidong He, Yufang Wang, Jingyao Sun [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2024

Comparison of clinical and endoscopic efficacy between vedolizumab and infliximab in bio-naïve patients with ulcerative colitis: a multicenter,real-world study

Zhaopeng Huang, Jian Tang, Ruibin Wu [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2017-10

The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine

Giuseppe Frieri, Brigida Galletti, Mirko Di Ruscio [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2020-5

Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn’s disease: A multicenter Israeli study

Ariella Bar-Gil Shitrit, Ami Ben-Ya’acov, Matan Siterman [...]

United European Gastroenterology Journal

Free access

Research article

First published 2020-11

Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study

Fabio Salvatore Macaluso, Walter Fries, Sara Renna [...]

United European Gastroenterology Journal

Open access

Research article

First published 2023

Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study

Piotr Eder, Maria Kłopocka, Halina Cichoż-Lach [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2013-4

Minimising steroids in lupus nephritis – will B cell depletion pave the way?

L Lightstone

Lupus

Search results